Evidence map›Paper›PMID 41746611›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2026

Building Trust and Engaging Communities for HIV Prevention Research Globally.

Michele Andrasik, Gail Broder, Kimberly Louis, Kagisho Baepanye, Luciana Kamel, Annet Davis, Patricia Segura, Blossom Makhubalo, Mariadel Rosario Leon Rhandomy, Jorge Soler and 10 more

Abstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Michele AndrasikFred Hutchinson Cancer Center, Seattle, Washington.
Gail BroderFred Hutchinson Cancer Center, Seattle, Washington.
Kimberly LouisSeattle Vaccine Trials Unit, Fred Hutchinson Cancer Center, Seattle, Washington.
Kagisho BaepanyeHutchinson Centre Research Institute of South Africa (HCRISA).
Luciana KamelInstituto Nacional de Infectologia Evandro Chagas, Fiocruz, Brazil.
Annet DavisUniversity of Pennsylvania.
Patricia SeguraFred Hutchinson Cancer Center, Seattle, Washington.
Blossom MakhubaloThe Aurum Institute.
Mariadel Rosario Leon RhandomyImpacta Salud y Educacion Peru Clinical Trials Unit.
Jorge SolerNew York Blood Center, New York, New York.
Sherri Karas CertoUniversity of Pittsburgh Clinical Research Site.
Rafael GonzalezFred Hutchinson Cancer Center, Seattle, Washington.
Waltana DawitSeattle Vaccine Trials Unit, Fred Hutchinson Cancer Center, Seattle, Washington.
Sascha ReinsteinPeru Clinical Trials Unit.
Cody E ShipmanFred Hutchinson Cancer Center, Seattle, Washington.
Linly SeyamaJohns Hopkins Project Blantyre, Malawi.
Hugo Sanchez SarmientoEl Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Epicentro, Lima, Peru.
Nombeko Cynthia MpongoDesmond Tutu HIV Foundation, Emavundleni Clinical Research Site.
Edith SwannU.S. National Institute of Allergies and Infectious Diseases.
Neetha S MorarSouth African Medical Research Council (SAMRC).

Funding

LOC: HIV Vaccine Trials NetworkUM1AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Dan H. Barouch, Lawrence Corey · 2011 to 2026
$1175.6M
NIAID NIH HHS UM1 AI068614
6 · The paper itself

Abstract

The HIV Vaccine Trials Network (HVTN) is the largest publicly funded international collaboration facilitating the evaluation of vaccines to prevent HIV and TB. Central to the HVTN's success is the reliance on robust community engagement methods, ensuring community participation and facilitating community awareness and knowledge of research. Community engagement is a dynamic process that requires active participation from all stakeholders to ensure success. The HVTN and its global Clinical Research Sites (CRSs) located in Africa, Latin America, and North America are known as the Network. We describe relationships across the Network, specific staff roles and responsibilities, and the myriad activities undertaken to ensure optimal community engagement. Key activities include involving active Community Advisory Boards (CABs), using community consultations, and having trained Community Engagement staff at each CRS. Operating with robust community engagement has resulted in rapid enrollment and high retention of diverse participant populations across Network studies.

Indexed as

AIDS VaccinesCommunity ParticipationHIV InfectionsTrustAfricaClinical Trials as TopicCommunity-Based Participatory ResearchGlobal HealthHumansInternational CooperationLatin AmericaNorth AmericaAIDS Vaccinescommunity engagementHIV preventionvaccine trials

Identifiers

PMID41746611
PMCPMC13138779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.